{"name":"Tango Therapeutics, Inc.","slug":"tango-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNcTgxVmJSSmwzS3FnSVl0TXJLMkRBaWVaX0J3MWxfSlRTeDZKeUYwUlVYOGVVYTBMQnR6U21TSjdfR1Y3bG90REoyeS1IU3VYS0dQeGlscno1MWFiUV84NjByOEZtV1JXWEFTc1pJY0lEWV9zRHVuM2NfUmxJZTc2c3ZJZ21nOEZpU0ZWWGtXMTU5cUVNaF9SZVR6R1VxRE9KNUZlNlpzSG8?oc=5","date":"2026-03-30","type":"pipeline","source":"Seeking Alpha","summary":"Tango Therapeutics is the best performing healthcare stock in March (XLV:NYSEARCA) - Seeking Alpha","headline":"Tango Therapeutics is the best performing healthcare stock in March (XLV:NYSEARCA)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPWjRQMDJVanZ2bkNCZmlkMjlGOWIyeHlSdEdUSF9hWGl0WUZfQmpRX2RGaU5oM0NMZlhVTVJQRnlWYm9tby1XOUJ1UUNISVNJdmtTVHZCQ2p1dE80b2Vsa3RqYWdzT2lfX2p6b010aEt2U2NOb05oNGJudGptUERUUkJoaXhlY3JySVpTaGV5S3o2OTR2Yi1sY0tTTQ?oc=5","date":"2026-03-09","type":"pipeline","source":"Yahoo Finance","summary":"X4 Pharmaceuticals, Immuneering and Tango Therapeutics Are Getting New Analyst Attention - Yahoo Finance","headline":"X4 Pharmaceuticals, Immuneering and Tango Therapeutics Are Getting New Analyst Attention","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPd01CUnJpTWZtbFkyOGQ0TVBfSElBZ2ZGazZ2ZFRMa2NTU0RGcTdGQjBRdjFMNVpyOGpDcHRSSmxoTmN6SmlqeHMwTUNDeTJBVDBQZ2Mycm9TQU9uRUhRUTBscWNLbTFnQV9wc2RVcFA2TzVXQVdvVm9qdUZHR2ZxakdiUjNNam8yNFNpZTNtOVJsdXBidy1GZnh3czNydw?oc=5","date":"2026-03-06","type":"deal","source":"Finviz","summary":"TNGX Stock Hits Record High on Inking Collaboration Deal With ERAS - Finviz","headline":"TNGX Stock Hits Record High on Inking Collaboration Deal With ERAS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOOE14NWJGcm1NQTJacTd0VHpGek1RVkVOMHBzVE45dE80U1BySVFpWlJQb1hQX1J2dDVPMkpnNkpyZlRUQ3N3MXRDTEpVOThPUGhWMGRlckI2WWNjOXZGYk50MWlXcU1INDkzNndNNXd3ZUZ1T2Vpb2E0UnNhR3lUVjdQT0FSOWFFSlFBdmFsSDR6TXdhS3BrZkZmVzdtS3pTQkZvQ0pheHRocXE1V2pHMWRlWQ?oc=5","date":"2026-03-06","type":"deal","source":"Seeking Alpha","summary":"Tango Therapeutics: I'm Not Buying Into Latest Rally, Despite PRMT5 Promise (NASDAQ:TNGX) - Seeking Alpha","headline":"Tango Therapeutics: I'm Not Buying Into Latest Rally, Despite PRMT5 Promise (NASDAQ:TNGX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxOUzA5NFpjT1ZxLTdmREZVaVJYc3VrRXJQazljdjFrcHNEUUZmeVdEN09GSnl4bFVsUUdNb3RnTmRNUDA2Y2JWQkY1VVE1OW9ZakNsWkJPVXV4SmlIY3ZYaF8wUHd2RXBXOWNib2cxTFl2S2lXZWVIbmNPQzcyWl9FOG9lOHJ3MnItOXdSWGNDQkxGVnIwUGdGZHhYVU9yQjRqUWdwc0p3dkZlUVBIMDZsNmJldWkwYjZOWUVVV1I4WnF4RVk0U2tjbjB4RkhEN0tQY0VKS1VuNFJwZ3MyWl9ick84SW9SSjBqdU5BandsSmJ5OFRSNTdKYkFZbllIWEt5MFNzZjBmdk84SDcyWktiSg?oc=5","date":"2026-03-05","type":"earnings","source":"globenewswire.com","summary":"Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights - globenewswire.com","headline":"Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNTWtaWnE4VWhMQ2RtYkVBRW10QkRmb2xWaE5NOGZKMC1pcXlFRDJIR251Ymd2Q2FaOHpha1E0Wm4zd09MZ1h5VGhvWUdsS0I5ZWZPcC1oOXBlaHZEd2pjLVZCMkp4N2x0X2VPdGtDQzQ1YnhWTllIMFRWLVYxZ2VBaTFsWFBoaFRLTlBPcFYyYkNVVXZqMTRwaXMwd28?oc=5","date":"2026-03-05","type":"deal","source":"Mugglehead Magazine","summary":"Tango Therapeutics rallies after oncology drug collaboration with Erasca - Mugglehead Magazine","headline":"Tango Therapeutics rallies after oncology drug collaboration with Erasca","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxPRDlTaUJaMnE1bVJDTHhGZ0lCUV9WcEJZRzJ4TmFlZDFvbExZc01IZlViZmZNdmxGU1RhOEhBZmVDZWdrYi1QeVIybE5mTGFzNjhoUUlmYjBsaW1iWm5Md29sbWNGRlM3MU94U193WW5mQzl6SkRPTEREUmlkZklzSG9jTFl4YUdsejlJZ1UzMFlTVklqUUhDeF9sekV5UzMzclFhdEFtRWtwdVVfaTdJN2JkUDNOTWtudllVbFA3MW1pVTlybTFRcFppZG1RaUwxY2NzREx3M3FPc042UXRsUzNzM0dkUdIB6wFBVV95cUxPU1MyOVdSdlY0QjhDb3RJVmgxeHo2Wk9kWFQyQ1JsSEszbjB6cmNlajl3R1o1N3R1aE1DYU0tMmVGUkV4ZGc4OE85MnFnZC14MjNYcGNaLUJKRUNGWktNaG1nT3dqUDMyeUtYRVMwZTR0LXJXOW45bVNFZ3JqbzZlM01jV284YU1tckRVdVVZdk5mMzBLcnR5NWpaQW9yLVkxcnVpaC1XWkxVbFFEN2tIOFZrbmpYaDB2NUJEVFliQlU3NXFyQ1diVENqSnkycTQ5emQ2SWpWbjFWTFFab2hsTkVoWlk4aFpaZ0kw?oc=5","date":"2026-01-19","type":"earnings","source":"simplywall.st","summary":"Tango Therapeutics, Inc.'s (NASDAQ:TNGX) 53% Price Boost Is Out Of Tune With Revenues - simplywall.st","headline":"Tango Therapeutics, Inc.'s (NASDAQ:TNGX) 53% Price Boost Is Out Of Tune With Revenues","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNNF8yRVVRdmFIVnN4aUFZOXpLSzhrUU1nZE1Wd241MllMMldSMVROMmduVHJKa1lEZS1kMFQ3MTIzcXhBTVVOR1RCSGZWRk1ZMXFraTRZTmNYODc1dEY4VGdUelUxM0pnWWVwd09LaHpOd0xOUGd3OWZ4eV9JODNWYnVUd1ZkMkZleGd3?oc=5","date":"2025-12-31","type":"pipeline","source":"The Business Journals","summary":"More than 4,600 Massachusetts biotech workers lost jobs in 2025 as industry contracts - The Business Journals","headline":"More than 4,600 Massachusetts biotech workers lost jobs in 2025 as industry contracts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNLVdfSEF4d19LT01QZnFsWG9hVTkxWUxqMXlKS0tSSXY5NFl0Mng4MUJTdDRoM1pubEFYbW1FWnpzWHJ2QjkxakE5MHE2THBSc2hLcHJXcDMzUFZVR0pRWm9ZclVOOHIwdG5HMWJDdHRpZXBrMC1teGJmYTdLeE9NcVVvaTMxS0cyR2NGay1DSHpOTmdWR0JUVkJiYU82QQ?oc=5","date":"2025-12-12","type":"pipeline","source":"Investing News Network","summary":"Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance - Investing News Network","headline":"Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxNZ3RKaXczc3J5MFgzektEU0wybmJoZFRQcnFYU05veTNSMXQtRzJuU3JwZnRvVHFvM1JSUXVyVDNlX2VwQXVPTWhEeDFHWjIzeldPNWxqSnQtLVVHZVlHV1lIa2VsMnZGN19nYzJkYWdaQ3VoNFE4eXZNdG55MTc1LXRRSUluOWttc2xrRXZiUFJkZGZrajQ2TzlqZW1yZ0tkakVaaFdFRktVWGEwRk1LQ3d4OERTZW5OSmlBbk1iLUc4SmJhUzFOS3pIcG5JMmVjbXg0S25SSFd6eTZuRzdBUlhnRmY3SndMenlWTFV5RzlpRFZ3bTEw?oc=5","date":"2025-10-29","type":"earnings","source":"globenewswire.com","summary":"Tango Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 - globenewswire.com","headline":"Tango Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxPSHNtMWdPQVg1R1o0YW05QUxxSjRPTFE3UDhhLTJJa3YtMXdzNmVvcTI2Yk1OYW1ZNjh2R0lhQWtHVDhDQmFKd0h3UHl4OW95OVhxOEc0WDRONG5XZWxCWHV3NEFJUjYyM1hCdjJzbFhXUTlOUjA1cTlxdHdnYm9oUEI4RUhtTGhDY3NUaTFoVHp2dEV4T05ua19HbDJTQlRiR2dnQTdISDN1cVlGaS1ZS045R1dzblVQN2tkNkQwZXI4b0oxV29lRktndW12VUR1MzBBZUZJc0hpQWJSRlkwcWZ0TWJkb0XSAewBQVVfeXFMTU04YS1YV3dFQ2REejVhcl83MlJHQXNlSlFfdHpQak5neDBiOXVGX29jeHlGUmQzeTNPX1RKVTk1OUhxNVlRQWhrbW03NXBxMVh0OHRhcFpYUnpNeEtVRVMzNTNVMnYwekVXdkV1TDBLZDlUQjBPMV9BaUNTdFpidGkyaVVDZW1wNzdHek1HRV9sZTQ0MjZ1Ny1peDhTZ0t6QTFRT3dYWGJuOVhLNnBNa3BVTFU4ZWljRlhqWldmOXkzdmczbVlVTDBjOVJwcmxnU2NUMDRZM0pIRi1tbVdqLWNzWkJDeVZsSldhUGg?oc=5","date":"2025-05-15","type":"pipeline","source":"simplywall.st","summary":"US$10.43: That's What Analysts Think Tango Therapeutics, Inc. (NASDAQ:TNGX) Is Worth After Its Latest Results - simplywall.st","headline":"US$10.43: That's What Analysts Think Tango Therapeutics, Inc. (NASDAQ:TNGX) Is Worth After Its Latest Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPdmVNVktRLVJreFo1bDEyWUFtVVk1SHJEbFhjWXlnbUNOQlZnVHJseHY4Yk5yU3piZDRSV0Fwc2lsa3huZ2pEOGlma3ZCOG5NbUxscnktOURHOEJ4dkFWVVo0cTZ3bGFCZERIdG5tRV9uWkozU2lycGRUa0xuRVFtSkYyVHJSNk9jWVZwZA?oc=5","date":"2025-04-07","type":"pipeline","source":"BioPharma Dive","summary":"Tango Therapeutics cuts nearly one-fifth of staff - BioPharma Dive","headline":"Tango Therapeutics cuts nearly one-fifth of staff","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}